Market News

Wall Street Analysts Think Brinker International (EAT) Is a Good Investment: Is It?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock’s price. Do they really matter, though?

Let’s take a look at what these Wall Street heavyweights have to say about Brinker International (EAT) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.

Brinker International currently has an average brokerage recommendation (ABR) of 1.95, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 21 brokerage firms. An ABR of 1.95 approximates between Strong Buy and Buy.

Of the 21 recommendations that derive the current ABR, 11 are Strong Buy, representing 52.4% of all recommendations.

Brokerage Recommendation Trends for EAT

Broker Rating Breakdown Chart for EAT

Check price target & stock forecast for Brinker International here>>>

While the ABR calls for buying Brinker International, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.

Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every “Strong Sell” recommendation, brokerage firms assign five “Strong Buy” recommendations.

In other words, their interests aren’t always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock’s price movement.

With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock’s near-term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.

Zacks Rank Should Not Be Confused With ABR

In spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures.

Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers — 1 to 5.

It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers’ vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.

See also  Insightful Analysis Of Recent Executive Changes in the Cannabis Industry Deep Dive Into Regulatory Changes

In a recent development in New York, a wave of high-profile exits rocked the Office of Cannabis Management (OCM), signaling a significant shift in leadership. The resignation of top officials such as Danielle Holmes, Nicole Rosa, Patricia Piskorski Heer, and pending departure of Linda Baldwin indicates a tumultuous period for the regulatory body. This shake-up follows Governor Kathy Hochul's punitive action against former OCM head Chris Alexander, marking a pivotal moment in New York's cannabis landscape.

New Leadership Emerges in Connecticut

Meanwhile, Connecticut witnessed a fresh chapter in its cannabis social equity initiative with Brandon McGee taking the helm at the Social Equity Council. McGee's appointment underscores a renewed focus on equitable practices within the state's burgeoning recreational marijuana market. This transition sets the stage for innovative policies and inclusive strategies to drive the industry forward.

CEO Transformations in Major Cannabis Companies

Turning to the corporate arena, notable shifts in executive leadership have captivated the cannabis sector. Canopy Growth Corporation made headlines with CEO David Klein's impending retirement announcement, ushering in a new era for the cannabis giant. Similarly, Curaleaf Holdings, Inc. witnessed a change at the top, appointing Boris Jordan as the new CEO, in a strategic move aimed at steering the company towards future growth.

Verde Financial Solutions Inc. took decisive action by naming Crystal K Morris as its new CEO, a transition prompted by ethical considerations. This shift underlines the importance of integrity and accountability in the fast-evolving cannabis ecosystem, emphasizing the need for responsible leadership to navigate industry complexities.

Stability and Growth in Cannabis Boardrooms

Boardroom dynamics have also seen significant alterations, with companies like Village Farms International, Inc. securing leadership continuity through a contract extension for CEO Michael A. DeGiglio. This move reflects a commitment to stability and long-term strategic vision, ensuring seamless operations and sustained growth trajectory.

Moreover, MariMed Inc.'s appointment of Mario Pinho as chief financial officer signifies a focus on financial prudence and operational excellence, essential components for sustainable business performance in the competitive cannabis landscape.

On the governance front, Aurora Cannabis Inc. and Agrify Corporation showcased robust board structures with key appointments, reinforcing their commitment to governance best practices and strategic oversight in an increasingly complex regulatory environment.

These sweeping changes in executive suites and boardrooms underscore a transformative phase in the cannabis industry, characterized by leadership realignment and strategic recalibration to meet evolving market demands. As industry stalwarts make way for fresh perspectives and innovative strategies, the future of cannabis appears poised for dynamic growth and sustainable success.

Corporate Leadership Changes: A Shift in Board Dynamics A New Era in Boardroom Dynamics: Key Leadership Changes in Corporate World

On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.

There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.

Should You Invest in EAT?

In terms of earnings estimate revisions for Brinker International, the Zacks Consensus Estimate for the current year has increased 0.3% over the past month to $10.23.

Analysts’ growing optimism over the company’s earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Brinker International. You can see the complete list of today’s Zacks Rank #1 (Strong Buy) stocks here >>>>

Therefore, the Buy-equivalent ABR for Brinker International may serve as a useful guide for investors.

Zacks Naming Top 10 Stocks for 2026

Want to be tipped off early to our 10 top picks for the entirety of 2026? History suggests their performance could be sensational.

From 2012 (when our Director of Research Sheraz Mian assumed responsibility for the portfolio) through November, 2025, the Zacks Top 10 Stocks gained +2,530.8%, more than QUADRUPLING the S&P 500’s +570.3%.

Now Sheraz is combing through 4,400 companies to handpick the best 10 tickers to buy and hold in 2026. Don’t miss your chance to get in on these stocks when they’re released on January 5. 

Be First to New Top 10 Stocks >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Brinker International, Inc. (EAT) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.